APA

Mushtaq A., Iftikhar A., Hassan H., Lakhani M., Sagar F., Kamal A., Zahid U., Ali Z., Razzaq F., Zar M. A., Hassan S. F., Safdar A., Raychaudhuri S. & Anwer F. (20200804). Pomalidomide-Based Regimens for Treatment of Relapsed and Relapsed/Refractory Multiple Myeloma: Systematic Review and Meta-analysis of Phase 2 and 3 Clinical Trials. : Clinical lymphoma, myeloma & leukemia.

Chicago

Mushtaq Adeela, Iftikhar Ahmad, Hassan Hamza, Lakhani Midhat, Sagar Fnu, Kamal Ahmad, Zahid Umar, Ali Zeeshan, Razzaq Faryal, Zar Muhammad Abu, Hassan Syeda Fatima, Safdar Ahmad, Raychaudhuri Sreejata and Anwer Faiz. 20200804. Pomalidomide-Based Regimens for Treatment of Relapsed and Relapsed/Refractory Multiple Myeloma: Systematic Review and Meta-analysis of Phase 2 and 3 Clinical Trials. : Clinical lymphoma, myeloma & leukemia.

Harvard

Mushtaq A., Iftikhar A., Hassan H., Lakhani M., Sagar F., Kamal A., Zahid U., Ali Z., Razzaq F., Zar M. A., Hassan S. F., Safdar A., Raychaudhuri S. and Anwer F. (20200804). Pomalidomide-Based Regimens for Treatment of Relapsed and Relapsed/Refractory Multiple Myeloma: Systematic Review and Meta-analysis of Phase 2 and 3 Clinical Trials. : Clinical lymphoma, myeloma & leukemia.

MLA

Mushtaq Adeela, Iftikhar Ahmad, Hassan Hamza, Lakhani Midhat, Sagar Fnu, Kamal Ahmad, Zahid Umar, Ali Zeeshan, Razzaq Faryal, Zar Muhammad Abu, Hassan Syeda Fatima, Safdar Ahmad, Raychaudhuri Sreejata and Anwer Faiz. Pomalidomide-Based Regimens for Treatment of Relapsed and Relapsed/Refractory Multiple Myeloma: Systematic Review and Meta-analysis of Phase 2 and 3 Clinical Trials. : Clinical lymphoma, myeloma & leukemia. 20200804.